Evidence map›Paper›PMID 33126600›Full record

ArticleMicroorganisms2020

A Retrospective Epidemiological Study of Tick-Borne Encephalitis Virus in Patients with Neurological Disorders in Hokkaido, Japan.

Kentaro Yoshii, Ikuko Takahashi-Iwata, Shinichi Shirai, Shintaro Kobayashi, Ichiro Yabe, Hidenao Sasaki

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023
    Article
  6. Tick-Borne Encephalitis-Review of the Current Status.Journal of clinical medicine · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kentaro YoshiiLaboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.ORCID 0000-0002-1104-0898
Ikuko Takahashi-IwataDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Shinichi ShiraiDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Shintaro KobayashiLaboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Ichiro YabeDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Hidenao SasakiDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Hokkaido University · JP

Funding

Pfizer an Investigator-Initiated Research Grant by Pfizer (WI239078)
6 · The paper itself

Abstract

Tick-borne encephalitis (TBE) is a zoonotic disease that usually presents as a moderate febrile illness followed by severe encephalitis, and various neurological symptoms are observed depending on the distinct central nervous system (CNS) regions affected by the TBE virus (TBEV) infection. In Japan, TBE incidence is increasing and TBEV distributions are reported in wide areas, specifically in Hokkaido. However, an extensive epidemiological survey regarding TBEV has not been conducted yet. In this study, we conducted a retrospective study of the prevalence of antibodies against TBEV in patients with neurological disorders and healthy populations in a TBEV-endemic area in Hokkaido. Among 2000 patients, three patients with inflammatory diseases in the CNS had TBEV-specific IgM antibodies and neutralizing antibodies. The other four patients diagnosed clinically with other neurological diseases were positive for TBEV-specific IgG and neutralizing antibodies, indicating previous TBEV infection. In a total of 246 healthy residents in a TBEV-endemic region, one resident had TBEV-specific antibodies. These results demonstrated undiagnosed TBEV infections in Japan. Further surveys are required to reveal the actual epidemiological risk of TBE and to consider preventive measures, such as a vaccine program, for the control of TBE in Japan.

Indexed as

epidemiologyneurological disorderticktick-borne encephalitiszoonosis

Identifiers

PMID33126600
PMCPMC7692117
OpenAlexW3095066748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.